Serial #97752503
DEAD

Serial Number

97752503

Owner

Chan Zuckerberg Biohub, Inc.

Attorney

Anthony Malutta

Filing Date

Jan 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97752503 Trademark

Serial Number: 97752503

Serial #97752503 is a trademark filed by Chan Zuckerberg Biohub, Inc. on January 12, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Chan Zuckerberg Biohub, Inc. (9 trademarks)

San Francisco, CA 94158

Entity Type: 03

Trademark Details

Filing Date

January 12, 2023

Registration Date

Not Registered

Goods & Services

Arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, multimedia presentations and training in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science; providing a website featuring blogs in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science

Providing funding in the fields of scientific medical and biomedical research

Genetic testing for medical research purposes; medical diagnostic testing, monitoring and reporting services for research purposes; consulting services in the fields of diagnostic medical testing; providing genetic sequencing and consulting services for medical research purposes

Scientific research in the field of medicine; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the field of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the field of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Jul 17, 2023 MAB1
ABANDONMENT - EXPRESS MAILED
Jul 17, 2023 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jul 14, 2023 EXAR
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 3, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2023 NWOS
NEW APPLICATION ENTERED
Jan 16, 2023 NWAP